Inside NYSCF’s Cell Therapy for Macular Degeneration
Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, affecting almost 20 million Americans. Harnessing the transformative power of stem cells,...
35 Results
Clear Filters
Media Advisory: The NYSCF Annual Conference on Translational Stem Cell Research
The New York Stem Cell Foundation’s (NYSCF) 18th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
How Could Stem Cells Cure Blindness? Experts Discuss Their Investigational Stem Cell Therapy to Restore Vision
People over the age of 75 have nearly a 30% risk of developing age-related macular degeneration (AMD), which now affects 11 million in the United States....
2022 in Review
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
Scientist, Entrepreneur, and Hockey Dad: Meet NYSCF Interim CEO Derrick Rossi
Even if you don’t know Derrick Rossi, PhD, you almost certainly know Moderna: the company behind mRNA vaccine technology he co-founded that is protecting millions from...
The NYSCF Conference Returns in Person to Showcase Seminal Advances in Translational Stem Cell Research
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
Showing Up for Patients: Highlights of the 2022 NYSCF Gala & Science Fair
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
Stem Cell Science in Action: NYSCF Introduces New Drug Discovery Platform at SNF Nostos Conference
“My colleagues and I are delighted to bring the NYSCF lab to you here at SNF Nostos Health today, and to show you in real time...
What are Stem Cells, and How Can They Accelerate Better Treatments for Disease?
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
2021 in Review
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
Persisting Even When a Pandemic Delays a PhD: Meet Jenna Hall
When COVID-19 hit, Jenna Hall’s plans were completely upended. Set to embark on a PhD at the University of Melbourne in Australia, border closures meant an...
Showing Up For Science: Highlights of the NYSCF Gala
On October 5th, celebrities, scientists, and supporters ‘showed up for science’ at the The 2021 New York Stem Cell Foundation Gala. Hosted by CNN’s Chief Medical...
Envisioning a Brighter Future for Macular Degeneration Patients: Experts Unpack the Path to a Cell Therapy
Age-related macular degeneration (AMD) is a leading cause of vision loss, and those over the age of 75 have a nearly 30% risk of being affected....
A Cell Therapy in Development at NYSCF Could Give AMD Patients Their Sight Back
For patients with age-related macular degeneration (AMD), a cell therapy in development at the NYSCF Research Institute could provide what sounds like a miracle: the restoration...
NYSCF Advances Toward a Cell Therapy for Age-Related Macular Degeneration
The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
A Clearer Window Into Disease: Meet the Opera Phenix Microscope
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Building Bruch’s Membrane to Better Understand Macular Degeneration
The Context: Age-related macular degeneration (AMD) results from the death of retinal pigmented epithelial cells (RPEs) in the eye. Bruch’s membrane is a structure that sits...
NYSCF Collaboration Identifies Promising Drug for Treating Most Common Form of Macular Degeneration
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
What’s Next for Regenerative Medicine? NYSCF Drives Discussions at the World Stem Cell Summit
Last week, thousands of researchers and thought leaders gathered at the annual Phacilitate Leaders World and World Stem Cell Summit in Miami to discuss recent advancements...
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
Four NYSCF Innovators Featured In Nature Article on Embryonic Stem Cell Research
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
NYSCF Innovator Pioneers Treatment To Restore Vision In Macular Degeneration Patients
Thanks to a groundbreaking new stem cell treatment, patients with age-related macular degeneration (AMD) are getting their sight back. This treatment was pioneered by the inaugural...
Cutting-Edge Research Highlights The NYSCF Conference
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
Stem Cell Treatments
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...